Product
WTX212A
2 clinical trials
2 indications
Indication
Solid TumorsIndication
Lung CancerClinical trial
A MulticenterOpen LableDose Escalat Tion and Dose Expansion Clinical Study to Evaluate the Safety, Tolerance and Ini Itial Effectiveness of WTX212A Injection in Patients With Unresectable or Metasta Atic Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2024-08-30
Clinical trial
A Single-center, Open Label, Exploratory Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of WTX212A Injection Combined With PD -1/PD-L1 Monoclonal Antibody in Patients With Advanced Lung CancerStatus: Recruiting, Estimated PCD: 2024-10-30